Accelerating Research Activities to Increase Peyronie’s Disease Treatment Market Growth 2021 Industry Business Opportunities by 2028 | Endo International plc

Peyronie’s Disease Treatment Market has the potential to become the most influential market in the world, as it has played a notable role in printing positive impacts on the international economy. The global Peyronie’s Disease Treatment market report offers vital information to determine and study market expectations, market size, and the competitive environment. The research is derived from primary and secondary data sources and includes qualitative and quantitative details.

Peyronie’s disease (PD) is a condition in which the penis is bent or bent due to the development of plaque or fibrous scar tissue inside the penis. Types of erectile dysfunction include psychological erectile dysfunction, priapism characterized by a painful erection in the absence of sexual stimulation, and Peyronie’s disease which causes structural abnormalities of the penis.

Request a Free Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/61

Global Peyronie’s Disease Treatment Market: Drivers

The approval and launch of new drugs is expected to propel the growth of the global Peyronie’s disease treatment market during the forecast period. For example, in 2013, the United States Food and Drug Administration approved Xiaflex (Collagenase clostridium histolyticum) from BioSpecifics Technologies Corporation for the treatment of Peyronie’s disease in adult men.

In addition, R&D in the treatment of Peyronie’s disease is also expected to propel the growth of the global market. Peyronie’s Disease Treatment Market over the forecast period. Likewise, in July 2019, a team of researchers from Memorial Sloan-Kettering Cancer Center (United States) found no link between testosterone levels and the extent of penile deformity associated with Peyronie’s disease. .

Global Peyronie’s Disease Treatment Market: Opportunities

The guidelines for the treatment of Peyronie’s disease are expected to provide lucrative growth opportunities for players in the global Peyronie’s disease treatment market. For example, in May 2015, the American Urological Association presented the very first treatment guidelines for Peyronie’s disease recommending the use of Xiaflex.

Moreover, the guidelines for the treatment of Peyronie’s disease are also expected to help the market growth. For example, in 2018 the Canadian Urological Association (AUC) presented new guidelines recommending the use of a remodeling technique based on the Andromedical Penile Traction Device (ANDROPEYRONIA) in combination with injections. of collagenase for the treatment of patients with Peyronie’s disease.

This image has an empty alt attribute;  its filename is sales.png

Buy this research report here: https://www.coherentmarketinsights.com/insight/buy-now/61

Market trends:

Asia-Pacific is expected to experience significant growth in the global Peyronie’s disease treatment market, due to the approval and launch of new drugs in the region. For example, in September 2015, BioSpecifics Technologies Corp., a biopharmaceutical company, announced the first commercial sale of Xiaflex by Asahi Kasei Pharma Corporation for the treatment of Dupuytren’s contracture in Japan triggered a milestone payment of 1.0 million dollars to BioSpecifics.

Global Peyronie’s Disease Treatment Market: Competitive Landscape

The major players operating in the global Peyronie’s disease treatment market are Actelion Pharmaceuticals Ltd, Asahi Kasei Corporation, BioSpecifics Technologies Corporation, Endo Pharmaceuticals Inc., Eton Pharmaceutical, Petros Pharmaceuticals, Inc. and Swedish Orphan Biovitrum AB.

Global Peyronie’s Disease Treatment Market: Key Developments

Major players operating in the global Peyronie’s disease treatment market are focusing on R&D to expand their product portfolio. For example, in November 2021, Petros Pharmaceuticals, Inc. announced the extension of its program for investigational H100, a new, patented, non-invasive topical treatment in development for Peyronie’s disease.

Do you have specific requirements? Ask our experts: https://www.coherentmarketinsights.com/insight/talk-to-analyst/61

Contents:

  1. Research objective and hypothesis
    o Research objectives
    o Assumptions
    o Abbreviations
  2. Market Snapshot
    o Description of the report
    Definition and scope of the market
    o Executive summary
    • Market extract by type of product
    • Market extract by application
    • Market extract by technology
    • Market extract by end user
    • Market extract by region
    o Coherent Opportunity Map (COM)
  3. Analysis of market dynamics, regulations and trends
    o Market dynamics
    Conductors
    • Constraints
    • Market opportunities
    o Technological trends
    o PEST analysis
    o Impact analysis
  4. Global Peyronie’s Disease Treatment Market, By Product Type, 2021 – 2028 (USD Million)
    Presentation
    Market share analysis, 2016 and 2028 (%)
    • Year-on-year growth analysis, 2021 – 2028
    • Segment trends
    o Reagents and consumables
    • Introduction
    • Market size and forecast, and year-on-year growth, 2021 – 2028 (USD Million)
    o Software
    • Introduction
    • Market size and forecast, and year-on-year growth, 2021 – 2028 (USD Million)
    Instruments
    • Introduction
    • Market size and forecast, and year-on-year growth, 2021 – 2028 (USD Million)
  5. Global Peyronie’s Disease Treatment Market, By Application, 2021 – 2028 (USD Million)
    Presentation
    Market share analysis, 2016 and 2028 (%)
    • Year-on-year growth analysis, 2021 – 2028
    • Segment trends
    o Genomics
    • Introduction
    • Market size and forecast, and year-on-year growth, 2021 – 2028 (USD Million)
    o Proteomics
    • Introduction
    • Market size and forecast, and year-on-year growth, 2021 – 2028 (USD Million)
    o Diagnosis
    • Introduction
    • Market size and forecast, and year-on-year growth, 2021 – 2028 (USD Million)
    o Drug discovery
    • Introduction
    • Market size and forecast, and year-on-year growth, 2021 – 2028 (USD Million)
  6. Global Peyronie’s Disease Treatment Market, By Technology, 2021 – 2028 (USD Million)
    Presentation
    Market share analysis, 2016 and 2028 (%)
    • Year-on-year growth analysis, 2021 – 2028
    • Segment trends
    Microarrays
    • Introduction
    • Market size and forecast, and year-on-year growth, 2021 – 2028 (USD Million)
    o Microfluidics
    • Introduction
    • Market size and forecast, and year-on-year growth, 2021 – 2028 (USD Million)
  7. Global Peyronie’s Disease Treatment Market, By End User, 2021 – 2028 (USD Million)
    Presentation
    Market share analysis, 2016 and 2028 (%)
    • Year-on-year growth analysis, 2021 – 2028
    • Segment trends
    o Hospitals
    • Introduction
    • Market size and forecast, and year-on-year growth, 2021 – 2028 (USD Million)
    o Diagnostic laboratories
    • Introduction
    • Market size and forecast, and year-on-year growth, 2021 – 2028 (USD Million)
    o University and research institutes
    • Introduction
    • Market size and forecast, and year-on-year growth, 2021 – 2028 (USD Million)
    o Biotech and pharmaceutical companies
    • Introduction
    • Market size and forecast, and year-on-year growth, 2021 – 2028 (USD Million)

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, custom research reports, and advisory services. We are known for our actionable insights and authentic reports in a variety of fields including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually every field. and a comprehensive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reporting. We are also committed to playing a leading role in providing insight into various post-COVID-19 sectors and continue to deliver measurable and sustainable results to our clients.

Contact us

Mr. Shah
Consistent market information
1001 4th avenue, # 3200
Seattle, Washington 98154
Phone: United States +12067016702 / United Kingdom +4402081334027
Email: [email protected]


Source link

Comments are closed.